Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health topic
No spam. Unsubscribe anytime.
Grand Rapids to accept $261,659.45 from national Sandoz opioid settlement for treatment, prevention and abatement
Summary
The commission authorized participation in a partial national settlement with Sandoz Inc., projecting a one‑time payment of $261,659.45 to the city for opioid treatment, prevention and abatement uses.
The City Commission authorized Grand Rapids’ participation in a partial nationwide settlement with Sandoz Incorporated, a manufacturer of prescription opioids. City legal staff said participating municipalities expect to receive a one‑time payment of $261,659.45 for the city’s recovery share under the proposed settlement.
The city attorney’s office said settlement funds are designated for treatment, prevention and abatement activities addressing harms from the opioid epidemic. Commissioners noted that the funds will supplement local efforts and observed that federal CDBG and other federal investments have not fully filled treatment and recovery funding gaps.
There was no extended debate; commissioners voted in favor of the participation resolution. City staff will follow the settlement agreement’s distribution rules and the city’s internal allocation process for these funds.
